|
|||||
|
|
Impact of the Omics-Based Biomarkers on the Fluvoxamine’s Steady-State Concentration,Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder |
|
| Authors: | MS Zastrozhin VYu Skryabin VYu Smirnov AK Zastrozhina EV Kaverina DA Klepikov EA Grishina KA Ryzhikova IV Bure EA Bryun DA Sychev |
| Abstract: | |
| Keywords: | fluvoxamine pharmacogenetics biotransformation personalized medicine depressive spectrum disorders alcohol use disorder |